4//SEC Filing
Loew Caroline 4
Accession 0000950170-25-094831
CIK 0001971543other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 5:00 PM ET
Size
5.9 KB
Accession
0000950170-25-094831
Insider Transaction Report
Form 4
Loew Caroline
DirectorChief Executive Officer
Transactions
- Sale
Ordinary Shares
2025-07-07$2.43/sh−12,531$30,475→ 293,059 total
Footnotes (3)
- [F1]Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 14, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement that includes a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on March 27, 2024, and the sale does not represent a discretionary trade by the Reporting Person.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.43 to $2.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Includes 220,148 restricted stock units.
Documents
Issuer
Mural Oncology plc
CIK 0001971543
Entity typeother
Related Parties
1- filerCIK 0001989488
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 5:00 PM ET
- Size
- 5.9 KB